Angiex's Incubator/Accelerator Round

Angiex raised a round of funding on May 19, 2016. Investors include MassChallenge.

Angiex is a biotechnology company developing an antibody-drug conjugate therapy for cancer against a vascular target, TM4SF1. In addition to its drug development efforts, Angiex provides research serv…

Articles about Angiex's Incubator/Accelerator Round: